Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the main alternatives. This work focuses on studying macrolide resistance rates, genetic associated determinants and antibiotic consumption data in Spain, Europe and also on a global scale. Macrolide resistance (MR) determinants, such as ribosomal methylases (erm(B), erm(TR), erm(T)) or active antibiotic efflux pumps and ribosomal protectors (mef(A/E)-mrs(D)), are differently distributed worldwide and associated with different clonal lineages and mobile genetic elements. MR rates vary together depending on clonal dynamics and on antibiotic consumption applying selective pressure. Among Streptococcus, higher MR rates are found in the viridans group, Streptococcus pneumoniae and Streptococcus agalactiae, and lower MR rates are described in Streptococcus pyogenes. When considering different geographic areas, higher resistance rates are usually found in East-Asian countries and milder or lower in the US and Europe. Unfortunately, the availability of data varies also between countries; it is scarce in low- and middle- income countries from Africa and South America. Thus, surveillance studies of macrolide resistance rates and the resistance determinants involved should be promoted to complete global knowledge among macrolide resistance dynamics.
20 May 2021 in Journal of Antimicrobial Chemotherapy
To phenotypically and genetically characterize the antibiotic resistance determinants and associated mobile genetic elements (MGEs) among macrolide-resistant (MR) Streptococcus pyogenes [Group A streptococci (GAS)] clinical isolates collected in Barcelona, Spain. Antibiotic susceptibility testing was performed by microdilution. Isolates were emm and MLST typed and 55 were whole-genome sequenced to determine the nature of the macrolide resistance (MR) determinants and their larger MGE and chromosomal context. Between 1998 and 2018, 142 of 1028 GAS (13.8%) were MR. Among 108 isolates available for molecular characterization, 41.7% had cMLSB, 30.5% iMLSB and 27.8% M phenotype. Eight erm(B)-containing strains were notable in having an MDR phenotype conferred by an MGE encoding several antibiotic resistance genes. MR isolates were comprised of several distinct genetic lineages as defined by the combination of emm and ST. Although most lineages were only transiently present, the emm11/ST403 clone persisted throughout the period. Two lineages, emm9/ST75 with erm(B) and emm77/ST63 with erm(TR), emerged in 2016–18. The erm(B) was predominantly encoded on the Tn916 family of transposons (21/31) with different genetic contexts, and in other MGEs (Tn6263, ICESpHKU372 and one harbouring an MDR cluster called ICESp1070HUB). The erm(TR) was found in ICESp2905 (8/17), ICESp1108-like (4/17), ICESpHKU165 (3/17) and two structures described in this study (IMESp316HUB and ICESp3729HUB). The M phenotype [mef(A)-msr(D)] was linked to phage φ1207.3. Eight integrative conjugative element/integrative mobilizable element (ICE/IME) cluster groups were classified on the basis of gene content within conjugation modules. These groups were found among MGEs, which corresponded with the MR-containing element or the site of integration. We detected several different MGEs harbouring erm(B) or erm(TR). This is the first known description of Tn6263 in GAS and three MGEs [IMESp316HUB, ICESp3729HUB and ICESp1070HUB] associated with MR. Periods of high MR rates in our area were mainly associated with the expansion of certain predominant lineages, while in low MR periods different sporadic and low prevalence lineages were more frequent.
11 January 2025 in International Journal of Infectious Diseases
An increase in Streptococcus dysgalactiae subsp. equisimilis (SDSE) infections has been documented worldwide. This study aims to analyze invasive disease caused by SDSE (iSDSE) in adults over an 11-year period in Spain. We conducted a retrospective, laboratory-based study of iSDSE detected at Hospital Universitari de Bellvitge (HUB) from 2012 to 2022 (n = 89) and isolates collected in three Spanish hospitals in 2018 (n = 22). Clinical data from HUB were collected. Isolates were tested for antimicrobial susceptibility (European Committee on Antimicrobial Susceptibility Testing 2023), subjected to whole genome sequencing and analyzed for mobile genetic elements (MGEs). A mouse model was used to analyze virulence. iSDSE episodes at HUB occurred predominantly in older patients with comorbidities (particularly, diabetes, chronic heart disease, and malignancies). Whole genome sequencing revealed a high genetic diversity, with the most common lineages being CC15, CC17, and CC20. Various virulence factors, including the superantigen speG, were identified. Macrolides, lincosamides, and tetracyclines exhibited the highest resistance rates (>27%) and changed over time, linked to multiple MGEs. The mouse model highlighted the virulence of the CC20-stG62647 lineage, but these results were discordant with clinical data. iSDSE incidence is increasing and associated with older patients with comorbidities. Genetically, SDSE is diverse with a high capacity to integrate MGEs carrying resistance determinants. Mouse model studies showed the enhanced virulence of the CC20-stG62647 lineage. These findings underscore the need for ongoing surveillance of this emerging pathogen.
Tetracycline resistance in streptococci is mainly due to ribosomal protection mediated by the tet(M) gene that is usually located in the integrative and conjugative elements (ICEs) of the Tn916-family. In this study, we analyzed the genes involved in tetracycline resistance and the associated mobile genetic elements (MGEs) in Streptococcus dysgalactiae subsp. equisimilis (SDSE) causing invasive disease. SDSE resistant to tetracycline collected from 2012 to 2019 in a single hospital and from 2018 in three other hospitals were analyzed by whole genome sequencing. Out of a total of 84 SDSE isolates, 24 (28.5%) were resistant to tetracycline due to the presence of tet(M) (n = 22), tet(W) (n = 1), or tet(L) plus tet(W) (n = 1). The tet(M) genes were found in the ICEs of the Tn916-family (n = 10) and in a new integrative and mobilizable element (IME; n = 12). Phylogenetic analysis showed a higher genetic diversity among the strains carrying Tn916 than those having the new IME, which were closely related, and all belonged to CC15. In conclusion, tetracycline resistance in SDSE is mostly due to the tet(M) gene associated with ICEs belonging to the Tn916-family and a new IME. This new IME is a major cause of tetracycline resistance in invasive Streptococcus dysgalactiae subsp. equisimilis in our settings.
10 December 2025 in Antimicrobial Agents and Chemotherapy
This study reports the first DIM-1-producing Pseudomonas aeruginosa identified in Spain. The multidrug-resistant ST233 clone harbored the blaDIM-1 gene within the class 1 integron In1592, together with aminoglycoside resistance genes aph(3' ) and aphA . This mobilizable element is a fragment of the PAGI-18 genomic island previously identified in Poland, but with different flanking insertion sequences, suggesting independent acquisition events. These findings highlight the importance of genomic surveillance of rare resistance determinants and mobile genetic elements.
Acute otitis media (AOM) is one of the most prevalent infectious diseases in childhood, with Streptococcus pneumoniae and Haemophilus influenzae being the most commonly involved pathogens. Following the coronavirus disease 2019 (COVID-19) pandemic and the incorporation of 13-valent pneumococcal conjugate vaccine (PCV13) into the national immunization program, changes in pneumococcal invasive disease have been described, but data on AOM remain limited. This study aimed to evaluate the current bacterial etiology of pediatric AOM. Spontaneous otorrhea fluid (SOF) samples and optional nasopharyngeal samples (NP) were collected from children with AOM attending 13 primary care centers in southern Barcelona. Conventional culture and PCR were used for pathogen detection. Most frequent pathogens ( Streptococcus pyogenes , S. pneumoniae , and H. influenzae ) underwent antimicrobial susceptibility testing and whole-genome sequencing. A total of 145 SOF and 83 NP samples were obtained. Bacterial growth in SOF samples was detected by culture in 80.7% of the samples and by molecular methods in 91.7%. The predominant pathogens were H. influenzae (40.7%), S. pyogenes (35.2%), and S. pneumoniae (33.8%). Serotype 3 (mainly GPSC12-CC180) was the most frequent pneumococcal serotype (15.6%), and 23.8% of identified serotypes were included in PCV13 despite high vaccination coverage. Most of the S. pyogenes analyzed (43.1%) belonged to the emm1 -ST28 genotype, and 94.1% of H. influenzae isolates analyzed were non-typeable. These findings demonstrate a marked shift in AOM etiology in the post-PCV13 era, with H. influenzae emerging as the leading pathogen and an increase in S. pyogenes AOM. Continued surveillance is essential to inform future vaccination and prevention strategies. IMPORTANCE: This multicenter study provides new insights into the current epidemiology of acute otitis media (AOM) in children vaccinated with the 13-valent pneumococcal conjugate vaccine. First, it underscores the role of molecular methods in pathogen detection. Second, it adds new evidence of the lack of concordance between nasopharyngeal and spontaneous otorrhea fluid samples, particularly for S. pneumoniae . Third, whole-genome analysis confirmed the predominance of the GSPC12-clade Ia as the major contributor to the vaccine failures due to serotype 3 pneumococci. Fourth, we characterized the S. pyogenes lineages associated with its recent upsurge in AOM, which differs from those causing invasive disease in our area. Finally, our findings confirm the current dominance of non-typeable H. influenzae as the leading cause of AOM in vaccinated children.